Top Markets
Coin of the day
Tectonic Therapeutic, Inc. Tectonic Therapeutic, Inc.

Tectonic Therapeutic, Inc.

TECX
Rang in aandelen #11670
Tectonic Therapeutic, Inc. operates as a clinical-stage biotechnology firm... Tectonic Therapeutic, Inc. operates as a clinical-stage biotechnology firm dedicated to the identification and progression of biologic therapies, primarily therapeutic proteins and antibodies, that regulate the function of G-protein coupled receptors (GPCRs). The company leverages its proprietary GEODe technology platform to facilitate the discovery and development of these GPCR-targeted medicines. Its robust pipeline includes an RXFP1 agonist, currently undergoing Phase 1a and 1b clinical trials for the treatment of heart failure with preserved ejection fraction. Additional programs encompass a GPCR antagonist addressing hereditary hemorrhagic telangiectasia, a bi-functional GPCR modulator aimed at fibrosis, and various other GPCR modulators. Tectonic Therapeutic, Inc. is situated in Watertown, Massachusetts.
Aandeelprijs
$35.63
Laatst gesynchroniseerd: 2026-08-28
Marktkapitalisatie
$672.28M
Verandering (1 dag)
-2.92%
Verandering (1 jaar)
39.50%
Land
US
Handel Tectonic Therapeutic, Inc. (TECX)

Categorie

Koersgeschiedenis voor Tectonic Therapeutic, Inc. (TECX)
Hoogste slotkoers: $35.01 op 2026-08-01

Laagste slotkoers: $360.74 op 2018-06-01
Koersgeschiedenis van Tectonic Therapeutic, Inc. van 2018 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) 24.56%
2025 -58.38%
2024 195.42%
2023 72.46%
2022 -79.14%
2021 -73.01%
2020 -28.18%
2019 -9.11%
2018 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.53 -12.70%
AU
$138.18 473.58%
US
$759.27 7.20%
CH